Should I Buy ARDX? ARDX 2026 Analysis

Should You Buy Ardelyx Inc (ARDX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

7.690

1 Day change

-2.04%

52 Week Range

8.400

Analysis Updated At

2026/01/29

Ardelyx Inc (ARDX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial growth, bullish technical indicators, positive analyst sentiment, and significant upside potential in its price targets support this decision. Despite hedge fund selling, the overall outlook remains favorable for long-term growth.

Technical Analysis

The technical indicators are bullish. The MACD is positive and contracting, RSI is neutral at 65.32, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The price is currently near the pivot level of 7.598, with resistance levels at 8.236 and 8.63, suggesting room for upward movement.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Analysts have significantly raised price targets, with targets ranging from $14 to $19, citing strong revenue growth and underpenetrated markets.
The company has a strong financial position with increasing revenue and gross margins.
Positive sentiment around Ibsrela's growth potential and extended IP protection until 2041.

Neutral/Negative Catalysts

Hedge funds are selling, with a 129.11% increase in selling over the last quarter.
Stock trend analysis indicates a potential short-term downside of -1.72% in the next day and -4.41% in the next week.

Financial Performance

In Q3 2025, Ardelyx reported revenue growth of 12.30% YoY, reaching $110.33M. Net income improved by 19.78% YoY, and gross margin increased to 96.39%, up 14.76% YoY. EPS remained at 0. The company's financials show strong growth trends, supporting its long-term potential.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive on Ardelyx, with multiple firms raising price targets significantly in January 2026. Jefferies, Citi, BTIG, Raymond James, and Piper Sandler all maintain Buy or Strong Buy ratings, citing strong revenue growth, underpenetrated markets, and extended IP protection as key drivers for future growth.

6 Analyst Rating

Wall Street analysts forecast ARDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDX is 14.33 USD with a low forecast of 10 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

0 Hold

0 Sell

Strong Buy

Current: 7.850

Low

Averages

14.33

High

Current: 7.850

Low

Averages

14.33

High

TD Cowen

Buy

upgrade

$10 -> $13

AI Analysis

2026-01-29

New

Reason

TD Cowen

Price Target

$10 -> $13

AI Analysis

2026-01-29

New

upgrade

Buy

Reason

TD Cowen raised the firm's price target on Ardelyx to $13 from $10 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.

Jefferies

Buy

upgrade

$8 -> $15

2026-01-27

New

Reason

Jefferies

Price Target

$8 -> $15

2026-01-27

New

upgrade

Buy

Reason

Jefferies raised the firm's price target on Ardelyx to $15 from $8 and keeps a Buy rating on the shares. The firm, which views Ardelyx as "among the most underrated and under-the-radar biotech launches," sees continued Ibsrela execution in 2026, but also a significantly bigger tail driven by IBS-C, new CIC, and potentially longer run on its intellectual property. The firm estimates $1.5B-$2B in peak sales in 2035, up from a prior call of $1B in 2032, but sees further upside if the new 2041 formulation patent is defendable, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ARDX

Unlock Now

ARDX Should I Buy

ARDX Should I Buy

Should You Buy Ardelyx Inc (ARDX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch